tariquidar has been researched along with soman in 3 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (soman) | Trials (soman) | Recent Studies (post-2010) (soman) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 1,391 | 4 | 257 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joosen, MJ; Kuijpers, WC; van der Schans, MJ; van Dijk, CG; van Helden, HP; Wortelboer, HM | 1 |
| Hamelink, J; Joosen, MJA; Klaassen, SD; van den Berg, RM; Vester, SM | 1 |
| Cornelissen, AS; Hesseling, P; Joosen, MJA; Klaassen, SD; Lucassen, PJ; Meerhoff, GF; Vester, SM | 1 |
3 other study(ies) available for tariquidar and soman
| Article | Year |
|---|---|
Increasing oxime efficacy by blood-brain barrier modulation.
Topics: Animals; Antidotes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterases; Electrophoresis, Capillary; Male; Microdialysis; Oximes; Pyridinium Compounds; Quinolines; Rats; Rats, Wistar; Seizures; Soman | 2011 |
Increasing nerve agent treatment efficacy by P-glycoprotein inhibition.
Topics: Acetylcholinesterase; Animals; ATP Binding Cassette Transporter, Subfamily B; Atropine; Blood-Brain Barrier; Brain; Dogs; Madin Darby Canine Kidney Cells; Male; Nerve Agents; Oximes; Pyridinium Compounds; Quinolines; Rats; Rats, Wistar; Seizures; Soman; Substrate Specificity | 2016 |
Potentiation of antiseizure and neuroprotective efficacy of standard nerve agent treatment by addition of tariquidar.
Topics: Animals; Anticonvulsants; Astrocytes; Atropine; Brain; Cholinesterase Reactivators; Cholinesterases; Diazepam; Male; Microglia; Neurons; Neuroprotective Agents; Oximes; Pyridinium Compounds; Quinolines; Rats, Wistar; Seizures; Soman | 2018 |